Kenvue Inc. is a consumer health company. The Company’s differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, BAND-AID, Aveeno, Zyrtec, and Nicorette. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include pain care; cough, cold, and allergy; digestive health; smoking cessation; eye care; and other products. Self Care segments include brands such as Tylenol, Motrin, Nicorette, Benadryl, Zyrtec, Zarbee’s, ORSLTM, Rhinocort, and Calpol. The Skin Health and Beauty segment is focused on face and body care, as well as hair, sun, and other products. The Essential Health segment includes oral care, baby care, women’s health, wound care, and other products. Its portfolio includes Self Care, Skin Health and Beauty, and Essential Health products which connect with consumers across North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).
회사 코드KVUE
회사 이름Kenvue Inc
상장일May 04, 2023
설립일2022
CEOMr. Thibaut Mongon
직원 수22000
유형Ordinary Share
회계 연도 종료May 04
주소1 Kenvue Way
도시SUMMIT
증권 거래소NYSE Consolidated
국가United States of America
우편 번호07901
전화19088741200
웹사이트https://www.kenvue.com
회사 코드KVUE
상장일May 04, 2023
설립일2022
지난 5년 동안 총
2.32B
USD의 배당금이 분배되었습니다.
KVUE.NB Interim Cash Dividend of gross USD 0.205 paid on Feb 26, 2025 going ex on Feb 12, 2025
KVUE.NB Final Cash Dividend of gross USD 0.205 paid on Nov 27, 2024 going ex on Nov 13, 2024
KVUE.NB Interim Cash Dividend of gross USD 0.205 paid on Aug 28, 2024 going ex on Aug 14, 2024
KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on May 22, 2024 going ex on May 07, 2024
KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on Feb 28, 2024 going ex on Feb 13, 2024
KVUE.NB Final Cash Dividend of gross USD 0.2 paid on Nov 22, 2023 going ex on Nov 07, 2023
KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on Sep 07, 2023 going ex on Aug 25, 2023